These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26876460)

  • 1. Active Surveillance of Prostate Cancer in a Community Practice: How to Measure, Manage, and Improve?
    Gaylis F; Cohen E; Calabrese R; Prime H; Dato P; Kane CJ
    Urology; 2016 Jul; 93():60-7. PubMed ID: 26876460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing Continuous Quality Improvement in an Integrated Community Urology Practice: Lessons Learned.
    Gaylis F; Nasseri R; Salmasi A; Anderson C; Mohedin S; Prime R; Swift S; Dato P; Cohen E; Catalona W; Topp R; Friedman L; Kane C
    Urology; 2021 Jul; 153():139-146. PubMed ID: 33482125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology Practices.
    Luckenbaugh AN; Auffenberg GB; Hawken SR; Dhir A; Linsell S; Kaul S; Miller DC;
    J Urol; 2017 Mar; 197(3 Pt 1):621-626. PubMed ID: 27663459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active surveillance of prostate cancer: a questionnaire survey of urologists, clinical oncologists and urology nurse specialists across three cancer networks in the United Kingdom.
    Philippou Y; Raja H; Gnanapragasam VJ
    BMC Urol; 2015 Jun; 15():52. PubMed ID: 26070313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer.
    Tyson MD; Graves AJ; O'Neil B; Barocas DA; Chang SS; Penson DF; Resnick MJ
    JAMA Surg; 2017 Jan; 152(1):27-34. PubMed ID: 27653425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists.
    Ellis SD; Hwang S; Morrow E; Kimminau KS; Goonan K; Petty L; Ellerbeck E; Thrasher JB
    BMC Cancer; 2021 May; 21(1):649. PubMed ID: 34058998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice- vs Physician-Level Variation in Use of Active Surveillance for Men With Low-Risk Prostate Cancer: Implications for Collaborative Quality Improvement.
    Auffenberg GB; Lane BR; Linsell S; Cher ML; Miller DC
    JAMA Surg; 2017 Oct; 152(10):978-980. PubMed ID: 28636713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and policy perspectives on the adoption of active surveillance for low-risk prostate cancer.
    Frendl DM; Sokoloff MH
    Med Care; 2014 Jul; 52(7):576-8. PubMed ID: 24926703
    [No Abstract]   [Full Text] [Related]  

  • 9. Qualitative study on decision-making by prostate cancer physicians during active surveillance.
    Loeb S; Curnyn C; Fagerlin A; Braithwaite RS; Schwartz MD; Lepor H; Carter HB; Sedlander E
    BJU Int; 2017 Jul; 120(1):32-39. PubMed ID: 27611479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Patterns of care of patients with localized prostate cancer in Germany: a health care study with focus on active surveillance].
    Chun FK; Becker A; Kluth LA; Seiler D; Schnell D; Fisch M; Graefen M; Weissbach L
    Urologe A; 2015 Jan; 54(1):6-13. PubMed ID: 25391440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.
    Womble PR; Montie JE; Ye Z; Linsell SM; Lane BR; Miller DC;
    Eur Urol; 2015 Jan; 67(1):44-50. PubMed ID: 25159890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-year Active Surveillance Outcomes in a Contemporary Community Urology Cohort in the United States.
    Shelton JB; Paivanas TA; Buffington P; Ruyle SR; Cohen ES; Natale R; Mehlhaff B; Suh R; Bradford TJ; Koo AS; Kwan L; Shore N
    Urology; 2019 Aug; 130():72-78. PubMed ID: 31029668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in prostate cancer management.
    Burki TK
    Lancet Oncol; 2014 Sep; 15(10):e419. PubMed ID: 25328941
    [No Abstract]   [Full Text] [Related]  

  • 14. Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement.
    Merriel SWD; Hetherington L; Seggie A; Castle JT; Cross W; Roobol MJ; Gnanapragasam V; Moore CM;
    BJU Int; 2019 Jul; 124(1):47-54. PubMed ID: 30742733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Performance of Active Surveillance Selection Criteria in Diverse Urology Practices.
    Hawken SR; Womble PR; Herrel LA; Ye Z; Linsell SM; Hurley PM; Montie JE; Miller DC;
    J Urol; 2015 Nov; 194(5):1253-7. PubMed ID: 25981805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriateness Criteria for Active Surveillance of Prostate Cancer.
    Cher ML; Dhir A; Auffenberg GB; Linsell S; Gao Y; Rosenberg B; Jafri SM; Klotz L; Miller DC; Ghani KR; Bernstein SJ; Montie JE; Lane BR;
    J Urol; 2017 Jan; 197(1):67-74. PubMed ID: 27422298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Describing perspectives of health care professionals on active surveillance for the management of prostate cancer.
    Pang K; Fitch M; Ouellet V; Chevalier S; Drachenberg DE; Finelli A; Lattouf JB; So A; Sutcliffe S; Tanguay S; Saad F; Mes-Masson AM
    BMC Health Serv Res; 2018 Jun; 18(1):430. PubMed ID: 29884180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary Management of Incident Prostate Cancer in Large Community Urology Practices in the United States.
    Shelton JB; Buffington P; Augspurger R; Gaylis F; Cohen T; Mehlhaff B; Suh R; Bradford TJ; Kwan L; Koo AS; Shore N
    Urology; 2019 Jul; 129():79-86. PubMed ID: 30954610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer.
    Loeb S; Berglund A; Stattin P
    J Urol; 2013 Nov; 190(5):1742-9. PubMed ID: 23727309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Systematic Approach to Discussing Active Surveillance with Patients with Low-risk Prostate Cancer.
    Ehdaie B; Assel M; Benfante N; Malhotra D; Vickers A
    Eur Urol; 2017 Jun; 71(6):866-871. PubMed ID: 28129893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.